Public Comments to Agencies | Council For Citizens Against Government Waste

Public Comments to Agencies

Agency Comments

CAGW Files Reply Comments on the RIF Order Remand

CAGW files reply comments on the Restoring Internet Freedom Order Remand. Issues include Lifeline/Link Up; pole attachments; and, public safety communications.

Deborah Collier May 20, 2020
Agency Comments

CAGW Files Reply Comments with the FCC in the 5.9 GHz Proceeding

CAGW has long maintained that public resources like the 5.9 GHz band should be maximized to their fullest potential.

Deborah Collier April 28, 2020
Agency Comments

CCAGW Leads Coalition In Supports FCC's Proposed TVWS Rule

The proposed TVWS rule is a leap forward for those whose lives will be improved by this technology, and the coalition urges its adoption.

Peter Klensch April 27, 2020
Agency Comments

Coalition Submits Comments to CEQ on Proposed Updated NEPA Regulations

CCAGW joins coalition with 10 other free market groups in support of the CEQ's Propsed Updated Regulations for implementing NEPA.

Peter Klensch March 10, 2020
Agency Comments

CAGW Submits Comments to FDA on Drug Importation Proposed Rule

Comments to the Food and Drug Administration on Proposed Rule for Importing Drugs from Canada

Elizabeth Wright March 5, 2020
Agency Comments

CAGW Submits Comments to FCC on 5.850-5.925 GHz Band Usage

CAGW offers comments supporting the FCC's NPRM to expand and enhance the use of the 5.850 – 5.925 GHz spectrum band.

Peter Klensch February 21, 2020
Agency Comments

Comment to FDA on Draft Guidance for Importation of Certain Drugs

Citizens Against Government Waste's Comment on Draft Guidance: Importation of Certain Food and Drug Administration-Approved Human Prescription Drugs, Including Biological Products

Elizabeth Wright February 21, 2020
Agency Comments

Comment to CMS - Medicaid Fiscal Accountability Regulation (MFAR)

Medicaid is a federal and state funded program but is administered by the states.

Elizabeth Wright January 31, 2020
Agency Comments

CAGW Submits Comments to CMS on Transparency Rule

CAGW has long advocated for more market forces to be used in the U.S. healthcare system. 

Elizabeth Wright January 28, 2020
Agency Comments

Coalition Comments on Biosimilar and Interchangeable Insulin Guidance

CAGW and coalition partners share the FDA's deep commitment to the development of a robust biosimilars market and appreciate the Agency’s work to develop an efficient approval pathway for biosimilars to bring savings and access to America’s patients.

Peter Klensch January 28, 2020
Agency Comments

Coalition Urges Significant Changes to Proposed Commerce Rule

Coalition of taxpayer and consumer advocacy groups urges signficant changes to proposed Commerce rule that would grant broad, undefined powers to the deparment over small businesses.

Peter Klensch January 10, 2020
Agency Comments

CAGW Submits Comments to Bureau of Consumer Financial Protection on Payday Lending Rule

May 14, 2019 The Honorable Kathy Kraninger Director Bureau of Consumer Financial Protection 1700 G Street, NW Washington, D.C., 20552 Dear Director Kraninger:

Allen Johnson May 14, 2019

Pages

Sign Up For Email Updates


Optional Member Code